Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.

Atlas A, Gisslén M, Nordin C, Lindström L, Schwieler L.

Brain Behav Immun. 2007 Jan;21(1):86-91. Epub 2006 Apr 17.

PMID:
16603336
2.

Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.

Olsson SK, Sellgren C, Engberg G, Landén M, Erhardt S.

Bipolar Disord. 2012 Nov;14(7):719-26. doi: 10.1111/bdi.12009. Epub 2012 Oct 3.

PMID:
23030601
3.

Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.

Kepplinger B, Baran H, Kainz A, Ferraz-Leite H, Newcombe J, Kalina P.

Neurosignals. 2005;14(3):126-35.

4.

Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.

Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, Soto-Hernandez JL, Flores-Hernandez R, Nente F, Montes S, Rios C.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):337-43. doi: 10.1016/j.genhosppsych.2008.01.007.

PMID:
18585537
5.

Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.

Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.

J Psychiatr Res. 2007 Jan-Feb;41(1-2):144-51. Epub 2006 Jan 24.

PMID:
16434056
6.

Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis.

Holtze M, Mickiené A, Atlas A, Lindquist L, Schwieler L.

J Intern Med. 2012 Oct;272(4):394-401. doi: 10.1111/j.1365-2796.2012.02539.x. Epub 2012 Apr 19.

7.

HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.

Burger DM, Boucher CA, Meenhorst PL, Kraayeveld CL, Portegies P, Mulder JW, Hoetelmans RM, Beijnen JH.

Antivir Ther. 1997 Apr;2(2):113-7.

PMID:
11322275
8.

The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.

Lavebratt C, Olsson S, Backlund L, Frisén L, Sellgren C, Priebe L, Nikamo P, Träskman-Bendz L, Cichon S, Vawter MP, Osby U, Engberg G, Landén M, Erhardt S, Schalling M.

Mol Psychiatry. 2014 Mar;19(3):334-41. doi: 10.1038/mp.2013.11. Epub 2013 Mar 5.

9.
10.

Psychiatric symptoms and disorders in HIV infected mine workers in South Africa. A retrospective descriptive study of acute first admissions.

Säll L, Salamon E, Allgulander C, Owe-Larsson B.

Afr J Psychiatry (Johannesbg). 2009 Aug;12(3):206-12.

PMID:
19750249
11.

Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.

Demitrack MA, Heyes MP, Altemus M, Pigott TA, Gold PW.

Biol Psychiatry. 1995 Apr 15;37(8):512-20.

PMID:
7542489
12.

Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.

Holmberg D, Franzén-Röhl E, Idro R, Opoka RO, Bangirana P, Sellgren CM, Wickström R, Färnert A, Schwieler L, Engberg G, John CC.

Malar J. 2017 Jul 28;16(1):303. doi: 10.1186/s12936-017-1954-1.

13.

Serum kynurenic acid is reduced in affective psychosis.

Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H, Ford BN, Morris HM, Teague TK, Dantzer R, Savitz JB.

Transl Psychiatry. 2017 May 2;7(5):e1115. doi: 10.1038/tp.2017.88.

14.

CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis.

Carlborg A, Jokinen J, Jönsson EG, Erhardt S, Nordström P.

Psychiatry Res. 2013 Jan 30;205(1-2):165-7. doi: 10.1016/j.psychres.2012.08.021. Epub 2012 Sep 11.

15.

Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.

Schwieler L, Linderholm KR, Nilsson-Todd LK, Erhardt S, Engberg G.

Life Sci. 2008 Aug 1;83(5-6):170-5. doi: 10.1016/j.lfs.2008.05.014. Epub 2008 Jun 10.

PMID:
18590745
16.

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.

Nilsson LK, Linderholm KR, Engberg G, Paulson L, Blennow K, Lindström LH, Nordin C, Karanti A, Persson P, Erhardt S.

Schizophr Res. 2005 Dec 15;80(2-3):315-22. Epub 2005 Aug 25.

PMID:
16125901
17.

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.

Linderholm KR, Andersson A, Olsson S, Olsson E, Snodgrass R, Engberg G, Erhardt S.

Neuropharmacology. 2007 Dec;53(8):918-24. Epub 2007 Sep 20.

PMID:
17959203
18.

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.

Olsson SK, Samuelsson M, Saetre P, Lindström L, Jönsson EG, Nordin C, Engberg G, Erhardt S, Landén M.

J Psychiatry Neurosci. 2010 May;35(3):195-9.

19.

Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.

Kegel ME, Johansson V, Wetterberg L, Bhat M, Schwieler L, Cannon TD, Schuppe-Koistinen I, Engberg G, Landén M, Hultman CM, Erhardt S.

Psychiatry Res. 2017 Jan;247:105-112. doi: 10.1016/j.psychres.2016.11.017. Epub 2016 Nov 16.

PMID:
27886578
20.

Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV.

Douet V, Tanizaki N, Franke A, Li X, Chang L.

J Neuroimmune Pharmacol. 2016 Sep;11(3):549-61. doi: 10.1007/s11481-016-9668-7. Epub 2016 Apr 12.

Supplemental Content

Support Center